SC
SANA icon

Savant Capital’s Sana Biotechnology SANA Stock Holding History

Savant Capital’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43.5K Buy
+13,666
New +$44K ﹤0.01% 1830

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Savant Capital's SANA Position: Q2 2026 in Review

Savant Capital opened a new position in Sana Biotechnology (SANA) in Q2 2026: 13,666 shares worth $43.5K. The stake represents ﹤0.01% of the portfolio and ranks #1830 among its holdings.

211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Savant Capital held 13,666 shares of Sana Biotechnology worth $43.5K as of Q2 2026.
  • Sana Biotechnology was a new Savant Capital position in Q2 2026.
  • Sana Biotechnology made up ﹤0.01% of Savant Capital's portfolio in Q2 2026, its #1830 holding.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Savant Capital's 13F filing for Q2 2026, filed 10 Aug 2026.